6533b7d5fe1ef96bd1263bff
RESEARCH PRODUCT
MA15.02 Long-Term Safety and Clinical Activity Results from a Phase Ib Study of Erlotinib Plus Atezolizumab in Advanced NSCLC
Peter SchmidPaul FosterAndrés CervantesIndrani SarkarGenevive HernandezJessica SpahnCarol O'hearBrigette B.y. MaScott N. GettingerBenjamin BesseAfshin DowlatiVictoria M. VillaflorRebecca S. HeistDaniel B. CostaCharles M. Rudinsubject
0301 basic medicinePulmonary and Respiratory MedicineOncologymedicine.medical_specialtybusiness.industry03 medical and health sciences030104 developmental biology0302 clinical medicineOncologyAtezolizumab030220 oncology & carcinogenesisInternal medicinemedicineErlotinibLong term safetybusinessmedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2018-10-01 | Journal of Thoracic Oncology |